PPARA and Insulin resistance: PPARα expression is also decreased in the WAT of mice with genetically or HFD-induced obesity, and PPARα agonists can reduce adiposity and improve insulin resistance in such obese mouse models by stimulating both differentiation and fatty acid oxidation in adipocytes [81].